TITLE

HAART PREVENTS CVM PROGRESSION

PUB. DATE
February 2000
SOURCE
AIDS Patient Care & STDs;Feb2000, Vol. 14 Issue 2, p101
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Discloses research findings that patients taking highly active antiretroviral therapy (HAART) regimens may be able to stop taking their anti-CMV medications without progression of retinitis. Ability of HAART to rejuvenate the immune system sufficiently enough to control CMV retinitis without the need for additional medication; Cost of standard anti-CMV treatment.
ACCESSION #
2905835

 

Related Articles

  • Borderline Tuberculoid Leprosy: An Immune Reconstitution Phenomenon in a Human Immunodeficiency Virus-Infected Person. Lawn, S.D.; Wood, C.; Lockwood, D.N. // Clinical Infectious Diseases;1/1/2003, Vol. 36 Issue 1, pe5 

    Reports on the development of lesions owing to borderline tuberculoid leprosy in human immunodeficiency virus type-1 infected-patients, kept on active antiretroviral treatment. Association between lesions and changes in lymphocyte count; Suggestion of the role of immune reconstitution.

  • Maribavir.  // Drugs in R&D;2007, Vol. 8 Issue 3, p188 

    Maribavir is a novel benzimidazole riboside compound that is currently in clinical development with ViroPharma for the prevention of cytomegalovirus (CMV) infections in transplant patients. Maribavir is thought to inhibit viral DNA assembly and inhibit egress of viral capsids from infected cell...

  • Insidious virus steals our years. Hamzelou, Jessica // New Scientist;6/23/2012, Vol. 214 Issue 2870, p6 

    The article reports on the cytomegalovirus (CMV) which ages the immune system of infected individuals, shortening their life spans. Topics include the global prevalence of CMV, how the human immune system responds to CMV infection, and research by Paul Moss and colleagues at the University of...

  • Cell Medica Raises £1.95M to Expand Cell Therapy Work. Moran, Nuala // BioWorld International;9/23/2009, Vol. 14 Issue 38, p2 

    The article reports that Cell Medica Ltd. raised 1.95 million British pounds from existing shareholders to develop further applications for its cell therapy technique for protecting patients with weakened immune systems against cytomegalovirus (CMV) infections. Cell Medica's Virus-specific...

  • ganciclovir. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p330 

    An encyclopedia entry for "ganciclovir" is presented. It refers to an antiviral drug that is used to treat cytomegalovirus infection. Such an illness occurs in those individuals whose immune system is impaired or suppressed for several reasons. The drug is toxic and produces a range of side...

  • Deal watch: Merck invests in pioneering cytomegalovirus programme. Crunkhorn, Sarah // Nature Reviews Drug Discovery;Dec2012, Vol. 11 Issue 12, p896 

    The article offers information on Merck & Co. Inc. has agreed to pay AiCuris for researches in human cytomegalovirus programme. It mentions that CMV is a herpesvirus that can infect people of all ages, remaining latent within the body but reactivating and shedding when the immune system is...

  • Treat HIv-1 Infected with at Least Two Antiretrovirals.  // Kidney;Sep/Oct99, Vol. 8 Issue 5, p203 

    Discusses an abstract of the article, entitled `Effect of hemodialysis and antiretroviral therapy on plasma viral load in HIV-1 infected hemodialysis patients,' by T.S. Ahuja, N. Niaz. A. Velasco and others.

  • VIRACEPT COMBINATIONS STUDIES.  // AIDS Patient Care & STDs;Jun98, Vol. 12 Issue 6, p495 

    Presents information on the fifth Conference on Retroviruses and Opportunistic Infections in Chicago in 1998. Summarization of the results from clinical trials of the drug Viracept; Use of the drug with other protease inhibitors and anti-human immunodeficiency virus (HIV) drugs; Evaluation of...

  • Stavudine Once Daily. Cheer, S.M.; Goa, K.L. // Drugs;2002, Vol. 62 Issue 18, p2667 

    â–´ Stavudine administered once daily is a nucleoside analogue reverse transcriptase inhibitor. â–´ The efficacy (reduction in viral load and increase in CD4+ lymphocyte counts from baseline) of stavudine once daily-containing triple therapy was similar to that of stavudine immediate...

Share

Other Topics